Cargando…
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Though the pathophysiology of clinical obesity is undoubtedly multifaceted, several lines of clinical evidence implicate an important functional role for glucagon-like peptide 1 (GLP-1) signalling. Clinical studies assessing GLP-1 responses in normal weight and obese subjects suggest that weight gai...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155232/ https://www.ncbi.nlm.nih.gov/pubmed/28031776 http://dx.doi.org/10.4239/wjd.v7.i20.572 |